Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2002
Reporting Period: Single event date (August 14, 2002)
This filing serves as a regulatory disclosure regarding compliance with the Sarbanes-Oxley Act of 2002. It does not contain periodic financial results or operational updates.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a compliance report and does not include financial statements or pro forma financial information.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely addresses the submission of executive certifications required by law.
Guidance, Outlook, and Regulatory Disclosures
- Regulation FD Disclosure: On August 14, 2002, the Chief Executive Officer (Chane Graziano) and Chief Financial Officer (Susan M. Luscinski) submitted certifications required by 18 U.S.C. Section 1350, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
- Exhibits: The filing includes Exhibit 99.1 (CEO Certification) and Exhibit 99.2 (CFO Certification).
- Outlook: No forward-looking guidance or management commentary regarding future business prospects is included.
Investor Verification Checklist
- Verify the company's compliance status with the Sarbanes-Oxley Act of 2002.
- Confirm the identities of the certifying officers: Chane Graziano (CEO) and Susan M. Luscinski (CFO).
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial metrics.